Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, October 1999, p. 2383-2388, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
-Lactamase Production in Prevotella intermedia,
Prevotella nigrescens, and Prevotella pallens
Genotypes and In Vitro Susceptibilities to Selected
Antimicrobial Agents
Jaana
Mättö,1,*
Sirkka
Asikainen,1
Marja-Liisa
Väisänen,2
Birgitta
Von Troil-Lindén,1
Eija
Könönen,2
Maria
Saarela,1
Kari
Salminen,3
Sydney M.
Finegold,4 and
Hannele
Jousimies-Somer2
Research Laboratory, Institute of Dentistry,
University of Helsinki,1 and Anaerobe
Reference Laboratory, National Public Health
Institute,2 Helsinki, and Pfizer
Finland, Espoo,3 Finland, and
Wadsworth VA Medical Center, West Los Angeles,
California4
Received 30 November 1998/Returned for modification 22 March
1999/Accepted 16 July 1999
 |
ABSTRACT |
The present study investigated the
-lactamase production of 73 Prevotella intermedia, 84 Prevotella
nigrescens, and 14 Prevotella pallens isolates and
their in vitro susceptibilities to six antimicrobial agents. The
P. intermedia and P. nigrescens isolates
were recovered from oral and extraoral samples obtained from subjects
in two geographic locations from 1985 to 1995. The clonality of the
-lactamase-positive and
-lactamase-negative isolates and the
clustering of the genotypes were studied by arbitrarily primed-PCR
fingerprinting.
-Lactamase production was detected in 29% of
P. intermedia isolates, 29% of P. nigrescens
isolates, and 57% of P. pallens isolates. No difference in
the frequencies of
-lactamase production by P. intermedia and P. nigrescens between isolates
from oral and extraoral sites, between isolates obtained at different
time periods, or between P. intermedia isolates from
different geographic locations was observed. However, the P. nigrescens isolates from the United States were significantly
more frequently (P = 0.015)
-lactamase positive
than those from Finland. No association between the genotypes and
-lactamase production or between the genotypes and the sources of
the isolates was found. The penicillin G MICs at which 90% of the
isolates were inhibited were 8 µg/ml for P. intermedia, 8 µg/ml for P. nigrescens, and 16 µg/ml for P. pallens. For the
-lactamase-negative isolates, the
corresponding values were 0.031, 0.031, and 0.125 µg/ml, and for the
-lactamase-positive isolates, the corresponding values were 16, 8, and 32 µg/ml. All isolates were susceptible to
amoxicillin-clavulanate, cefoxitin, metronidazole, azithromycin, and
trovafloxacin. The MICs of amoxicillin-clavulanate and cefoxitin were
relatively higher for the
-lactamase-positive population than for
the
-lactamase-negative population.
 |
INTRODUCTION |
The Prevotella intermedia
group bacteria are black-pigmented, gram-negative anaerobic rods
that are commonly found as members of the polymicrobial flora in
various infections in humans (8, 24). The P. intermedia group includes two phenotypically indistinguishable species, P. intermedia and Prevotella nigrescens
(29). Moreover, several authors have found isolates
that biochemically resemble P. intermedia and P. nigrescens (4, 20, 24, 28). These include a
recently described, weakly pigmented, lipase-negative species,
Prevotella pallens (21). The primary site
of isolation of P. intermedia, P. nigrescens, and
P. pallens is the oral cavity. P. intermedia
is associated with periodontal disease (9, 22), whereas P. nigrescens and P. pallens can also be
detected in samples from periodontally healthy subjects (7, 9, 20,
22). In addition to occurring in the oral cavity, all three
species occur in extraoral infections (6, 20, 24).
Although several antibiotics, such as metronidazole, azithromycin, and
-lactam antibiotics combined with
-lactamase
inhibitors, are still generally active against pigmented
Prevotella species (35), resistance to
tetracyclines and penicillins is increasing (32). Penicillin
resistance due to
-lactamase production (32) is presently common in pigmented Prevotella species (3,
15, 17, 19, 31). The various frequencies of
-lactamase production of P. intermedia group
isolates (3, 19) may be explained by differences in the
geographic locations and sampling sites of the isolates. Knowledge
about the frequency of
-lactamase production as well as the
susceptibility patterns of P. intermedia, P. nigrescens, and P. pallens is limited, since in most
previous studies species differentiation was not performed or only a
limited number of isolates were tested. Furthermore, there are no
reports on the genetic heterogeneity of
-lactamase-producing isolates.
The aims of the present study were to investigate the
-lactamase production of P. intermedia, P. nigrescens, and P. pallens isolates and their
susceptibilities to six antimicrobial agents and to compare the
frequencies of
-lactamase production by P. intermedia and P. nigrescens isolates from oral samples
and various extraoral infections originating from two geographic
locations between 1985 and 1995. In addition, the clonality of
-lactamase-positive and -negative isolates and the
clustering of genotypes were studied by using arbitrarily primed PCR
(AP-PCR) for DNA fingerprinting.
 |
MATERIALS AND METHODS |
Bacterial isolates.
The material comprised 73 P. intermedia isolates, 84 P. nigrescens isolates,
and 14 P. pallens clinical isolates included in our previous
studies (20, 22-24). A total of 171 isolates were recovered
from oral and extraoral samples obtained from 164 subjects between 1985 and 1995. The isolates originated from two geographic locations:
Wadsworth Anaerobic Bacteriology Laboratory of the Veterans Affairs
Medical Center, Los Angeles, Calif., and the Anaerobe Reference
Laboratory, National Public Health Institute, and the Institute of
Dentistry, University of Helsinki, both in Helsinki, Finland (Table
1).
Established biochemical methods were used for presumptive
identification of the isolates as P. intermedia or P. nigrescens and as P. pallens (16, 21).
Species differentiation was performed by hybridization with P. intermedia- and P. nigrescens-specific oligonucleotide
probes and by multilocus enzyme electrophoresis of malate and glutamate
dehydrogenase enzymes, as previously described (22, 24). The
isolates were maintained in 20% skim milk at
70°C until used in
the present study.
-Lactamase test.
-Lactamase production was assessed by
using a chromogenic cephalosporin disk test (Biodisk, Solna, Sweden).
Bacteroides fragilis ATCC 25285 was included as a positive
control. The
2 test was used to determine the
statistical significance of the differences in the frequency of
-lactamase production between the isolates originating
from different sampling sites or geographic locations and at different
time periods.
Susceptibility testing.
The MICs of penicillin G,
amoxicillin-clavulanate (2:1), metronidazole, cefoxitin, azithromycin,
and trovafloxacin were determined by the Wadsworth agar dilution method
according to procedures outlined by the National Committee for Clinical
Laboratory Standards (NCCLS) (25). An inoculum of
105 CFU was delivered with a multipoint inoculator to
supplemented brucella-based, laked blood agar (BBL, Cockeysville, Md.).
The plates were incubated at 37°C for 48 h in jars filled with a
mixed gas (85% N2, 5% CO2, and 10%
H2). The appearance of growth was compared with that of the
control plate, and the MIC for each was defined as the lowest
concentration of antimicrobial agent resulting in no growth, one
discrete colony, or multiple tiny colonies. The MICs were determined by
one reader (J.M.), and the reference strains B. fragilis
ATCC 25285, Bacteroides thetaiotaomicron ATCC 29741, P. intermedia ATCC 25611, and P. nigrescens ATCC
33563 were included as controls in each test run.
AP-PCR amplification.
Clonal analysis of the P. intermedia, P. nigrescens, and P. pallens
isolates (171 clinical isolates and the type strains P. intermedia ATCC 25611 and P. nigrescens ATCC 33563) was
performed by using AP-PCR with the primer OPA-03
(5'-AGTCAGCCAC-3'; Operon Technologies, Alameda, Calif.),
which is highly discriminative for these species (23). DNA
extraction and PCR amplification were performed as previously described
(23).
AP-PCR fingerprinting analysis.
The amplified DNA fragments
were separated in a 1% agarose gel containing 0.5 µg of ethidium
bromide per ml and 0.5× Tris-borate-EDTA buffer at 100 V for 4 h.
A 1-kb ladder (Gibco BRL, Life Technologies, Inc., Gaithersburg, Md.)
was used in the outermost lanes of each gel as a molecular size marker
and as a reference for normalization of different gels. The gel
pictures were digitized and analyzed with the Taxotron program package
(Taxolab, Institut Pasteur, Paris, France). The error margin was set to
5%, and clustering was performed by using the unweighted pair-group
method with mathematical averages included in the package. Only the
bands with medium to high intensity were included in the computer
analysis, since the weak bands were not always reproducible.
 |
RESULTS |
Reference strains.
The control strains B. fragilis
ATCC 25285 and B. thetaiotaomicron ATCC 29741 were both
-lactamase positive, and the MICs were within acceptable
ranges (25), as follows: 16 to 32 and 16 to 32 µg/ml for
penicillin G, 0.5 and 0.5 to 1 µg/ml for amoxicillin-clavulanate, 8 and 32 µg/ml for cefoxitin, 0.5 and 1 to 2 µg/ml for metronidazole, 4 to 8 and 8 to 16 µg/ml for azithromycin, and 0.25 and 0.5 µg/ml for trovafloxacin, respectively. The reference strains P. intermedia ATCC 25611 and P. nigrescens ATCC 33563 were
-lactamase negative, and the MICs varied within two
dilutions between the test runs, 0.031 and 0.016 µg/ml for penicillin
G, 0.031 to 0.06 and 0.016 µg/ml for amoxicillin-clavulanate, 0.125 to 0.25 and 0.06 to 0.125 µg/ml for cefoxitin, 1 to 2 and 0.25 to 0.5 µg/ml for metronidazole, 0.125 to 0.25 and 0.125 µg/ml for
azithromycin, and 1 and 1 µg/ml for trovafloxacin, respectively.
-Lactamase production.
-Lactamase activity was detected
in 21 of 73 (28.8%) P. intermedia isolates in 24 of 84 (28.6%) P. nigrescens isolates, and in 8 of 14 (57.1%)
P. pallens isolates (Table 2).
No difference in the frequencies of
-lactamase
production by P. intermedia and P. nigrescens was
detected between isolates from extraoral sites and those from oral
sites or between P. intermedia isolates originating from the
United States and those originating from Finland. However,
-lactamase production was detected more frequently in
P. nigrescens isolates recovered from the United States than in those recovered from Finland (
2 test, P = 0.026). P. intermedia isolates obtained from 1991 to 1995 were significantly more often
-lactamase positive than
those isolated from 1985 to 1990 (
2 test,
P = 0.038), whereas no time-related difference was
observed for P. nigrescens. All P. pallens
isolates were recovered from the oral cavities of Finnish subjects
during the 1990s, and they were not included in the comparisons of the
source and time of recovery.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Frequency of -lactamase production in
P. intermedia, P. nigrescens, and P. pallens isolates, presented by site of infection or recovery,
geographic location, and time of isolation
|
|
Susceptibility.
The MICs of penicillin G were in the range of
0.016 to 16 µg/ml for P. intermedia and P. nigrescens and in the range of 0.06 to 32 µg/ml for P. pallens (MICs at which 90% of the isolates were inhibited
[MIC90s], 8, 8, and 16 µg/ml, respectively) (Table 3). According to the interpretive
categories of the NCCLS (25), 73% of P. intermedia isolates, 76% of P. nigrescens isolates, and 43% of P. pallens isolates were susceptible (MIC,
0.5
µg/ml) to penicillin G; 1, 4, and 0%, respectively, were
intermediate (MIC, 1 µg/ml) to penicillin G; and 26, 20, and 57%,
respectively, were resistant (MIC,
2 µg/ml) to penicillin G. The isolates of each species could be separated into two
categories according to the MICs and
-lactamase
production. One category included
-lactamase-positive isolates for which the MICs were
higher (
0.5 µg/ml for P. intermedia and P. nigrescens and
2 µg/ml for P. pallens) and the
other one included
-lactamase-negative isolates for
which the MICs were lower (
0.06 µg/ml for P. intermedia,
0.03 µg/ml for P. nigrescens, and
0.125 µg/ml for
P. pallens). The MIC breakpoint separating
-lactamase-positive and
-lactamase-negative isolates was 0.5 µg/ml.
Penicillin G MIC90s for
-lactamase-positive isolates (16, 8, and 32 µg/ml) were 8 to 10 dilution steps higher than those for
-lactamase-negative isolates (0.031, 0.031, and 0.125 µg/ml) (Table 4).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Susceptibilities of P. intermedia, P. nigrescens, and P. pallens to six antimicrobial
agents, as determined by the agar
dilution methoda
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 4.
MIC50s, MIC90s, and MIC ranges of
selected -lactam antibiotics for -lactamase-positive
and -lactamase-negative P. intermedia,
P. nigrescens, and P. pallens isolates
|
|
All isolates were susceptible to amoxicillin-clavulanate, cefoxitin,
metronidazole, azithromycin, and trovafloxacin (Table
3). No difference
between

-lactamase-positive and

-lactamase-negative
isolates in susceptibility to
metronidazole, azithromycin, or
trovafloxacin was detected.
However, the MIC
90 of metronidazole
for
P. intermedia (2.0 µg/ml) was two dilution steps higher than
that
for
P. nigrescens (0.5 µg/ml). The MIC
90 of
amoxicillin-clavulanate
and cefoxitin were three to five dilution
steps higher for

-lactamase-positive
isolates than for

-lactamase-negative isolates (Table
4).
AP-PCR.
The 21
-lactamase-positive P. intermedia isolates were of 20 AP-PCR types, the 24
-lactamase-positive P. nigrescens isolates were of 23 AP-PCR types, and the 8
-lactamase-positive
P. pallens isolates were of 7 AP-PCR types. The numbers of
AP-PCR types identified among the 54
-lactamase-negative
P. intermedia isolates, the 60
-lactamase-negative P. nigrescens
isolates, and the 6
-lactamase-negative P. pallens isolates were 51, 51, and 3, respectively. Figure
1 shows a dendogram of AP-PCR patterns of
P. intermedia, P. nigrescens, and
P. pallens displayed similar clustering (trees not shown). In two cases,
-lactamase-positive and
-lactamase-negative P. nigrescens isolates
were of the same AP-PCR type. The P. intermedia and P. pallens isolates having the same AP-PCR type were always similar in
-lactamase tests. The
-lactamase-positive isolates of all three species
were distributed into several clusters, and no correlation between the
AP-PCR patterns and
-lactamase production was observed.
In addition, no correlation between the site of isolation or geographic
location of the isolates and their AP-PCR patterns was found. The
isolates having the same AP-PCR type were recovered from unrelated
subjects, except for two P. intermedia isolates from two
sites from a single subject, two P. nigrescens isolates from
a married couple, and four P. pallens isolates from two
mother-child pairs. The AP-PCR types of P. intermedia,
P. nigrescens, and P. pallens displayed no
overlapping.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Dendogram and list indicating -lactamase
( -lact) production of the P. intermedia (P.i.) isolates
(73 clinical isolates and the type strain, ATCC 25611). Extraoral
isolates are underlined. The WAL isolates originated in the United
States, and all other isolates originated in Finland. The
-lactamase-positive isolates were scattered in several
clusters, and characteristics shared by isolates belonging to the same
cluster could not be found.
|
|
 |
DISCUSSION |
-Lactamase production was a common feature of P. intermedia, P. nigrescens, and P. pallens
isolates in the present study. The prevalence of
-lactamase production in the P. intermedia group, including P. nigrescens (29%), is well in accordance
with several earlier studies (4, 5, 15, 31). However, there are also studies in which higher (3) or lower
(19) prevalences have been reported. The discrepancies in
the frequencies may result from differences in the sources of the
isolates and in the histories of antibiotic therapy of the subjects.
Moreover, in most earlier studies P. intermedia and P. nigrescens were not identified to species level and they may have
been unevenly distributed in the material. In the present study
-lactamase-producing isolates were found with equal
frequencies in P. intermedia and P. nigrescens, which disagrees with a recent study by Bernal et al.
(4), in which
-lactamase production was
suggested to be a feature more common in P. nigrescens than
in P. intermedia. However, in the study by Bernal et al.
(4), only the
-lactamase-positive isolates were identified to species level. The P. pallens
isolates used for the present study were relatively more often
-lactamase positive than the P. intermedia
and P. nigrescens isolates, which agrees well with an
earlier study by Könönen et al. (19), in
which, contrary to P. pallens (formerly "P.
intermedia/nigrescens-like organism"), most P. nigrescens isolates obtained from young children were
-lactamase negative. P. intermedia was not
included in the study by Könönen et al. (19),
since the bacterium is not usually found in periodontally healthy
children or adults (7, 9, 22). In the present study, no
difference in the frequency of
-lactamase production
between isolates from extraoral and oral sites or between the P. intermedia isolates from different geographical locations was
detected, whereas
-lactamase-producing P. nigrescens isolates were detected statistically more often among
isolates from U.S. subjects than among those from Finnish subjects.
Most of the isolates from U.S. subjects were recovered from extraoral infections, whereas the isolates from the Finnish subjects originated from both healthy and diseased sites. Unfortunately, the antibiotic history of the subjects was not available, and it is possible that
there is a difference in the use of antibiotics between these subject
groups. Recent penicillin exposure is known to increase the prevalence
of penicillin-resistant microbial populations (17). An
increase in the penicillin resistance of pigmented
Prevotella over the past 10 to 15 years has been reported
(32), and an increase in the frequency of
-lactamase production was seen in the present
study among P. intermedia isolates but not among P. nigrescens isolates.
Penicillin-resistant, pigmented Prevotella isolates,
occasionally including P. intermedia and P. nigrescens isolates, have been reported in several previous
studies (6, 15, 17, 19). Penicillin-resistant isolates of
P. intermedia and P. nigrescens as well as of
P. pallens were also detected in the present study. All
penicillin-resistant isolates were
-lactamase producers, and the MIC (0.5 µg/ml) separating
-lactamase-positive
isolates from
-lactamase-negative isolates was well in
line with the value observed earlier (0.5 to 1 µg/ml) (6, 15,
17, 19). Interestingly, according to the MICs (0.5 µg/ml), one
-lactamase-positive P. intermedia isolate and
four P. nigrescens isolates of the present study belonged to
the susceptible category of the latest NCCLS standard (25),
which emphasizes the necessity of screening the pigmented
Prevotella species for
-lactamase.
All P. intermedia, P. nigrescens, and P. pallens isolates in the present study were susceptible to
amoxicillin-clavulanate and cefoxitin, although these agents were
relatively more active against
-lactamase-negative
isolates than against
-lactamase-positive isolates. Good
activity of cefoxitin and amoxicillin-clavulanate against pigmented
Prevotella has also been reported in earlier studies
(3, 6, 10). Consistent with the present finding, 100%
susceptibility of pigmented Prevotella species to
metronidazole has been observed in several previous studies (1,
14, 34). However, one metronidazole-resistant, pigmented
Prevotella isolate, from a sample taken from a subject with
pleuropulmonary infection, has been found (6). In the
present study, we detected MIC90s of metronidazole two
dilution steps higher for P. intermedia than for P. nigrescens. Although the MICs for P. intermedia
isolates were far below the breakpoint recommended for metronidazole
(16 µg/ml) (25), a gradual development of resistance is
possible, so resistance should be monitored. Azithromycin and
trovafloxacin also were highly active against all isolates in the
present study, which agrees well with earlier reports on
Bacteroides and Prevotella species (14, 30,
35). However, the MIC90s of azithromycin (0.125 µg/ml for P. intermedia and P. pallens and
0.06 µg/ml for P. nigrescens) were lower than those
reported in earlier studies, which included only a limited number of
P. intermedia and P. nigrescens isolates and no
P. pallens isolates (13, 26). Other investigators (1, 14, 30, 34) have reported good in vitro activity of
trovafloxacin, a recently described fluoroquinolone, against pigmented
Prevotella and other gram-negative anaerobes. Conversely, the activity of the older fluoroquinolones against anaerobes has generally been poor or modest (11, 34).
P. intermedia, P. nigrescens, and P. pallens species are genetically highly diverse (20, 22, 23,
28). Therefore, finding of isolates with identical AP-PCR types
from different subjects strongly suggests a common source of the
isolates. Consistent with an earlier study by Paquet and Mouton
(27), no association between the AP-PCR patterns and the
sampling sites or geographic locations of the present isolates was
found. Furthermore, there was no correlation between
-lactamase production and AP-PCR patterns. This agrees
with the results of the study by Könönen et al. (18) of Prevotella melaninogenica, a pigmented
indigenous oral anaerobe, indicating that isolates of the same ribotype
occasionally show variation in
-lactamase production.
Penicillin resistance in the P. intermedia group is due to a
constitutively produced broad-spectrum
-lactamase, which
is related but not identical to
-lactamases produced by
the B. fragilis group organisms (2, 33). There
are reports on conjugal transfer of the genes coding for
-lactamase from P. intermedia to other
Prevotella and Bacteroides species (12,
33). The transfer seems to be linked to transfer of the
tet(Q) gene, which codes for tetracycline resistance
(12, 33). The genetic heterogeneity of the present
-lactamase-producing P. intermedia and
P. nigrescens isolates suggests that, in addition to the
overgrowth of the resistant clones during antibiotic therapy, acquisition of the resistance genes by transfer and mutation may have a
role in the increase of penicillin resistance in these species.
Therefore, studies on similarity of genes coding for
-lactamase are needed to evaluate the significance of
horizontal gene transfer in these species.
In conclusion,
-lactamase production was common among
the P. intermedia, P. nigrescens, and P. pallens isolates of the present study.
-Lactamase-producing
isolates were genetically heterogeneous and originated from both
oral and extraoral sites as well as from different geographic
locations, the United States and Finland. Because of the enzymatic
hydrolysis of penicillin due to the
-lactamase production of these species and because of the horizontal transfer of
penicillin resistance determinants from P. intermedia to
different species (12), therapy with penicillin may not be
optimal in infections involving P. intermedia group
bacteria. Fortunately, several other antibiotics
(amoxicillin-clavulanate, cefoxitin, metronidazole,
azithromycin, and trovafloxacin) proved to be highly active
against these species.
 |
ACKNOWLEDGMENTS |
This study was supported by Academy of Finland grant 10131015 and
by the Emil Aaltonen Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: VTT
Biotechnology and Food Research, P.O. Box 1500 (Tietotie 2), FIN-02044
VTT, Finland. Phone: 358-9-456-5226. Fax: 358-9-455-2103. E-mail:
jaana.matto{at}vtt.fi.
 |
REFERENCES |
| 1.
|
Aldridge, K. E.,
D. Ashcraft, and K. A. Bowman.
1997.
Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes.
Antimicrob. Agents Chemother.
41:484-487[Abstract].
|
| 2.
|
Appelbaum, P. C.,
A. Philippon,
M. R. Jacobs,
S. K. Spangler, and L. Gutmann.
1990.
Characterization of -lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in -lactam resistance.
Antimicrob. Agents Chemother.
34:2169-2176[Abstract/Free Full Text].
|
| 3.
|
Appelbaum, P. C.,
S. K. Spangler, and M. R. Jacobs.
1990.
-Lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Antimicrob. Agents Chemother.
34:1546-1550[Abstract/Free Full Text].
|
| 4.
|
Bernal, L. A.,
E. Guillot,
C. Paquet, and C. Mouton.
1998.
-Lactamase-producing strains in the species Prevotella intermedia and Prevotella nigrescens.
Oral Microbiol. Immunol.
13:36-40[Medline].
|
| 5.
|
Brook, I.,
L. Calhoun, and P. Yocum.
1980.
Beta-lactamase-producing isolates of Bacteroides species from children.
Antimicrob. Agents Chemother.
18:164-166[Abstract/Free Full Text].
|
| 6.
|
Civen, R.,
H. Jousimies-Somer,
M. Marina,
L. Borenstein,
H. Shah, and S. M. Finegold.
1995.
A retrospective review of cases of anaerobic empyema and update of bacteriology.
Clin. Infect. Dis.
20(Suppl. 2):S224-S229.
|
| 7.
|
Conrads, G.,
R. Mutters,
J. Fischer,
A. Brauner,
R. Lütticken, and F. Lampert.
1996.
PCR reaction and dot-blot hybridization to monitor the distribution of oral pathogens within plaque samples of periodontally healthy individuals.
J. Periodontol.
67:994-1003[Medline].
|
| 8.
|
Finegold, S. M.,
C. A. Strong,
M. McTeague, et al.
1993.
The importance of black-pigmented gram-negative anaerobes in human infections.
FEMS Immunol. Med. Microbiol.
6:77-82[Medline].
|
| 9.
|
Gharbia, S. E.,
M. Haapasalo,
H. N. Shah,
A. Kotiranta,
K. Lounatmaa,
M. A. Pearce, and D. A. Devine.
1994.
Characterization of Prevotella intermedia and Prevotella nigrescens isolates from periodontic and endodontic infections.
J. Periodontol.
65:56-61[Medline].
|
| 10.
|
Goldstein, E. J. C., and D. M. Citron.
1986.
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals.
Antimicrob. Agents Chemother.
29:158-160[Abstract/Free Full Text].
|
| 11.
|
Goldstein, E. J. C.
1993.
Patterns of susceptibility of fluoroquinolones among anaerobic bacterial isolates in the United States.
Clin. Infect. Dis.
16(Suppl. 4):S377-S381.
|
| 12.
|
Guiney, D. G., and K. Bouic.
1990.
Detection of conjugal transfer systems in oral, black-pigmented Bacteroides spp.
J. Bacteriol.
172:495-497[Abstract/Free Full Text].
|
| 13.
|
Hardy, D. J.,
D. M. Hensey,
J. M. Beyer,
C. Vojtko,
E. J. McDonald, and P. B. Fernandes.
1988.
Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.
Antimicrob. Agents Chemother.
32:1710-1719[Abstract/Free Full Text].
|
| 14.
|
Hecht, D. W., and J. R. Osmolski.
1996.
Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Clin. Infect. Dis.
23(Suppl. 1):S44-S50.
|
| 15.
|
Jousimies-Somer, H.,
S. Savolainen,
A. Mäkitie, and J. Ylikoski.
1993.
Bacteriologic findings in peritonsillar abscesses in young adults.
Clin. Infect. Dis.
16(Suppl. 4):S292-S298.
|
| 16.
|
Jousimies-Somer, H. R.,
P. H. Summanen, and S. M. Finegold.
1995.
Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic gram-negative bacteria, p. 603-620.
In
P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. ASM Press, Washington, D.C.
|
| 17.
|
Kinder, S. A.,
S. C. Holt, and K. S. Korman.
1986.
Penicillin resistance in the subgingival microbiota associated with adult periodontitis.
J. Clin. Microbiol.
23:1127-1133[Abstract/Free Full Text].
|
| 18.
|
Könönen, E.,
M. Saarela,
A. Kanervo,
J. Karjalainen,
S. Asikainen, and H. Jousimies-Somer.
1995.
-Lactamase production and penicillin susceptibility among different ribotypes of Prevotella melaninogenica simultaneously colonizing the oral cavity.
Clin. Infect. Dis.
20(Suppl. 2):S364-S366.
|
| 19.
|
Könönen, E.,
S. Nyfors,
J. Mättö,
S. Asikainen, and H. Jousimies-Somer.
1997.
-Lactamase production by oral pigmented Prevotella species isolated from young children.
Clin. Infect. Dis.
25(Suppl. 2):S272-S274.
|
| 20.
|
Könönen, E.,
J. Mättö,
M.-L. Väisänen-Tunkelrott,
E. V. G. Frandsen,
I. Helander,
S. Asikainen,
S. M. Finegold, and H. Jousimies-Somer.
1998.
Biochemical and genetic characterization of a Prevotella intermedia/nigrescens-like organism.
Int. J. Syst. Bacteriol.
48:39-46[Abstract/Free Full Text].
|
| 21.
|
Könönen, E.,
E. Eerola,
E. V. G. Frandsen,
J. Jalava,
J. Mättö,
S. Salmenlinna, and H. Jousimies-Somer.
1998.
Phylogenetic characterization and proposal of a new pigmented species to the genus Prevotella: Prevotella pallens sp. nov.
Int. J. Syst. Bacteriol.
48:47-51[Abstract/Free Full Text].
|
| 22.
|
Mättö, J.,
M. Saarela,
B. von Troil-Lindén,
E. Könönen,
H. Jousimies-Somer,
H. Torkko,
S. Alaluusua, and S. Asikainen.
1996.
Distribution and genetic analysis of oral Prevotella intermedia and Prevotella nigrescens.
Oral Microbiol. Immunol.
11:96-102[Medline].
|
| 23.
|
Mättö, J.,
M. Saarela,
B. von Troil-Lindén,
S. Alaluusua,
H. Jousimies-Somer, and S. Asikainen.
1996.
Similarity of salivary and subgingival Prevotella intermedia and Prevotella nigrescens isolates by arbitrarily primed polymerase chain reaction.
Oral Microbiol. Immunol.
11:395-401[Medline].
|
| 24.
|
Mättö, J.,
S. Asikainen,
M.-L. Väisänen,
M. Rautio,
M. Saarela,
P. Summanen,
S. Finegold, and H. Jousimies-Somer.
1997.
Role of Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens in extraoral and some odontogenic infections.
Clin. Infect. Dis.
25(Suppl. 2):S194-S198.
|
| 25.
|
National Committee for Clinical Laboratory Standards.
1997.
Methods for antimicrobial susceptibility testing of anaerobic bacteria, 4th ed. Approved standard. NCCLS document M11-A4.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 26.
|
Neu, H. C.,
N. X. Chin,
G. Saha, and P. Labthavikul.
1988.
Comparative in vitro activity of the new oral macrolide azithromycin.
Eur. J. Clin. Microbiol. Infect. Dis.
7:541-544[Medline].
|
| 27.
|
Paquet, C., and C. Mouton.
1997.
RAPD fingerprinting for the distinction of Prevotella intermedia from Prevotella nigrescens.
Anaerobe
3:271-278.
|
| 28.
|
Pearce, M. A.,
R. A. Dixon,
S. E. Gharbia,
H. N. Shah, and D. A. Devine.
1996.
Characterization of Prevotella intermedia and Prevotella nigrescens by enzyme production, restriction endonuclease and ribosomal RNA gene restriction analysis.
Oral Microbiol. Immunol.
11:135-141[Medline].
|
| 29.
|
Shah, H. N., and S. E. Gharbia.
1992.
Biochemical and chemical studies on strains designated Prevotella intermedia and proposal of a new pigmented species, Prevotella nigrescens sp. nov.
Int. J. Syst. Bacteriol.
42:542-546[Abstract/Free Full Text].
|
| 30.
|
Väisänen, M.-L.,
J. Mättö,
K. Salminen, and H. Jousimies-Somer.
1997.
In vitro activity of trovafloxacin against anaerobic bacteria.
Rev. Med. Microbiol.
8(Suppl. 1):S81-S83.
|
| 31.
|
Van Winkelhoff, A. J.,
E. G. Winkel,
D. Barendregt,
N. Dellemijn-Kippuw,
A. Stijne, and U. van der Velden.
1997.
-Lactamase producing bacteria in adult periodontitis.
J. Clin. Periodontol.
24:538-543[Medline].
|
| 32.
|
Walker, C. B.
1996.
The acquisition of antibiotic resistance in the periodontal microflora.
Periodontology 2000
10:79-88[Medline].
|
| 33.
|
Walker, C. B., and L. C. Bueno.
1997.
Antibiotic resistance in an oral isolate of Prevotella intermedia.
Clin. Infect. Dis.
25(Suppl. 2):S281-S283.
|
| 34.
|
Wexler, H. M.,
E. Molitoris,
D. Molitoris, and S. M. Finegold.
1996.
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
Antimicrob. Agents Chemother.
40:2232-2235[Abstract].
|
| 35.
|
Wexler, H. M.,
E. Molitoris, and D. Molitoris.
1997.
Susceptibility testing of anaerobes: old problems, new options?
Clin. Infect. Dis.
25(Suppl. 2):S275-S278.
|
Antimicrobial Agents and Chemotherapy, October 1999, p. 2383-2388, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Duncan, M. J.
(2003). GENOMICS OF ORAL BACTERIA. CROBM
14: 175-187
[Abstract]
[Full Text]
-
Handal, T., Caugant, D. A., Olsen, I.
(2003). Antibiotic Resistance in Bacteria Isolated from Subgingival Plaque in a Norwegian Population with Refractory Marginal Periodontitis. Antimicrob. Agents Chemother.
47: 1443-1446
[Abstract]
[Full Text]